| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681664 | Clinical Neurology and Neurosurgery | 2018 | 15 Pages |
Abstract
Results of our study in accordance to previous ones suggest AM-GPi DBS as an effective and well-tolerated therapeutic modality for patients with medication refractory TS.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Alireza Azimi, Mansour Parvaresh, Gholamali Shahidi, Amirhassan Habibi, Sadra Rohani, Mahdi Safdarian, Arash Fattahi, Morteza Taheri, Mohammad Rohani,